Antibody‐dependent Cytotoxicity Mediated by Chimeric Monoclonal Antibody Nd2 and Experimental Immunotherapy for Pancreatic Cancer

In a previous study, mouse monoclonal antibody (MoAb) Nd2 (m‐Nd2, mouse IgGl) labeled with (131) I exhibited efficacy in in vivo radioimmunotherapy against pancreatic cancer. In this study we prepared mouse/human chimeric antibody Nd2 (c‐Nd2, human IgG1) for clinical use and examined whether c‐Nd2 i...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishihara, Tamahiro, Sawada, Tetsuji, Yamamoto, Atsushi, Yamashita, Yoshito, Ho, Jenny J. L., Kim, Young‐Sik, Chung, Kosei Hirakawa‐YS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2000
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926427/
https://www.ncbi.nlm.nih.gov/pubmed/10965023
http://dx.doi.org/10.1111/j.1349-7006.2000.tb01019.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5926427/
https://www.ncbi.nlm.nih.gov/pubmed/10965023
http://dx.doi.org/10.1111/j.1349-7006.2000.tb01019.x

Ejemplares similares